{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:38Z","timestamp":1790912498996,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T00:00:00Z","timestamp":1465603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T00:00:00Z","timestamp":1465603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK069629"],"award-info":[{"award-number":["R01 DK069629"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM044931"],"award-info":[{"award-number":["R01 GM044931"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00216-016-9677-7","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T09:34:34Z","timestamp":1465637674000},"page":"5745-5756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["On-column entrapment of alpha1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography"],"prefix":"10.1007","volume":"408","author":[{"given":"Jeanethe","family":"Anguizola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Koke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,11]]},"reference":[{"key":"9677_CR1","first-page":"657","volume-title":"Encyclopedia of drug metabolism and interactions","author":"LH Cohen","year":"2012","unstructured":"Cohen LH, Nicoll-Griffith DA. Plasma protein binding methods in drug discovery and development: bioanalysis. In: Lyubimov AV, editor. Encyclopedia of drug metabolism and interactions. Hoboken: Wiley; 2012. p. 657\u201374."},{"key":"9677_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/138920011795202938","volume":"12","author":"DS Hage","year":"2011","unstructured":"Hage DS, Anguizola J, Barnaby O, Jackson A, Yoo MJ, Papastavros E, et al. Characterization of drug interactions with serum proteins by using high-performance affinity chromatography. Curr Drug Metab. 2011;12:313\u201328.","journal-title":"Curr Drug Metab"},{"key":"9677_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","volume":"64","author":"NA Kratochwil","year":"2002","unstructured":"Kratochwil NA, Huber W, Muller F, Kansy M, Gerber PR. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol. 2002;64:1355\u201374.","journal-title":"Biochem Pharmacol"},{"key":"9677_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpba.2012.10.030","volume":"74","author":"K Vuignier","year":"2013","unstructured":"Vuignier K, Guillarme D, Veuthey JL, Carrupt PA, Schappler J. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions. J Pharm Biomed Anal. 2013;74:205\u201312.","journal-title":"J Pharm Biomed Anal"},{"key":"9677_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-4347(01)00482-0","volume":"768","author":"DS Hage","year":"2002","unstructured":"Hage DS. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J Chromatogr B. 2002;768:3\u201330.","journal-title":"J Chromatogr B"},{"key":"9677_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/138920307779941497","volume":"8","author":"F Ceciliani","year":"2007","unstructured":"Ceciliani F, Pocacqua V. The acute phase protein \u03b11-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci. 2007;8:91\u2013108.","journal-title":"Curr Protein Pept Sci"},{"key":"9677_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1081\/DMR-100104402","volume":"33","author":"ZH Israili","year":"2001","unstructured":"Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev. 2001;33:161\u2013235.","journal-title":"Drug Metab Rev"},{"key":"9677_CR8","first-page":"247","volume-title":"Acute phase proteins\u2014regulation and functions of acute phase proteins","author":"C Tesseromatis","year":"2011","unstructured":"Tesseromatis C, Alevizou A, Tigka E, Kotsiou A. Acute-phase proteins: alpha-1-acid glycoprotein. In: Veas F, editor. Acute phase proteins\u2014regulation and functions of acute phase proteins. Rijeka: InTech; 2011. p. 247\u201360."},{"key":"9677_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF01037957","volume":"25","author":"DL Goolkasian","year":"1983","unstructured":"Goolkasian DL, Slaughter RL, Edwards DJ, Lalka D. Displacement of lidocaine from serum \u03b11-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol. 1983;25:413\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"9677_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/clpt.1980.46","volume":"27","author":"PA Routledge","year":"1980","unstructured":"Routledge PA, Barchowsky A, Bjornsson TD, Kitchell BB, Shand DG. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980;27:347\u201351.","journal-title":"Clin Pharmacol Ther"},{"key":"9677_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<751::AID-JPS6>3.0.CO;2-8","volume":"89","author":"K Hanada","year":"2000","unstructured":"Hanada K, Ohta T, Hirai M, Arai M, Ogata H. Enantioselective binding of propranolol, disopyramide, and verapamil to human \u03b11-acid glycoprotein. J Pharm Sci. 2000;89:751\u20137.","journal-title":"J Pharm Sci"},{"key":"9677_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/clpt.1984.93","volume":"35","author":"DI Freilich","year":"1984","unstructured":"Freilich DI, Giardina EG. Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients. Clin Pharmacol Ther. 1984;35:670\u20134.","journal-title":"Clin Pharmacol Ther"},{"key":"9677_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2125.1984.tb02462.x","volume":"18","author":"F Albani","year":"1984","unstructured":"Albani F, Riva R, Contin M, Baruzzi A. Stereoselective binding of propranolol enantiomers to human \u03b11-acid glycoprotein and human plasma. Br J Clin Pharmacol. 1984;18:244\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"9677_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/bmc.1130090504","volume":"9","author":"R Kaliszan","year":"1995","unstructured":"Kaliszan R, Nasal A, Turowski M. Binding site for basic drugs on \u03b11-acid glycoprotein as revealed by chemometric analysis of biochromatographic data. Biomed Chromatogr. 1995;9:211\u20135.","journal-title":"Biomed Chromatogr"},{"key":"9677_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cpt1977225part1545","volume":"22","author":"KM Piafsky","year":"1977","unstructured":"Piafsky KM, Borga O. Plasma protein binding of basic drugs. II. importance of alpha1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther. 1977;22:545\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"9677_CR16","first-page":"51","volume":"88","author":"CM Lai","year":"1995","unstructured":"Lai CM, Moore P, Quon CY. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin. Res Commun Mol Pathol Pharmacol. 1995;88:51\u201362.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"9677_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.envint.2006.11.017","volume":"33","author":"Y Kim","year":"2007","unstructured":"Kim Y, Choi K, Jung J, Park S, Kim PG, Park J. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int. 2007;33:370\u20135.","journal-title":"Environ Int"},{"key":"9677_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2125.1993.tb04224.x","volume":"36","author":"F Herve","year":"1993","unstructured":"Herve F, Gomas E, Duche JC, Tillement JP. Evidence for differences in the binding of drugs to the two main genetic variants of human \u03b11-acid glycoprotein. Br J Clin Pharmacol. 1993;36:241\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"9677_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00007691-199310000-00014","volume":"15","author":"KP Leow","year":"1993","unstructured":"Leow KP, Wright AW, Cramond T, Smith MT. Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit. 1993;15:440\u20137.","journal-title":"Ther Drug Monit"},{"key":"9677_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/clpt.1986.119","volume":"39","author":"S Urien","year":"1986","unstructured":"Urien S, Albengres E, Pinquier JL, Tillement JP. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin. Clin Pharmacol Ther. 1986;39:683\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"9677_CR21","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1016\/0006-2952(82)90597-4","volume":"31","author":"S Urien","year":"1982","unstructured":"Urien S, Albengres E, Zini R, Tillement JP. Evidence for binding of certain acidic drugs to \u03b11-acid glycoprotein. Biochem Pharmacol. 1982;31:3687\u20139.","journal-title":"Biochem Pharmacol"},{"key":"9677_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1042\/bj2890767","volume":"289","author":"S Urien","year":"1993","unstructured":"Urien S, Bree F, Testa B, Tillement JP. pH-dependence of warfarin binding to \u03b11-acid glycoprotein (orosomucoid). Biochem J. 1993;289:767\u201370.","journal-title":"Biochem J"},{"key":"9677_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1046\/j.1365-2125.2003.01909.x","volume":"56","author":"T Nakagawa","year":"2003","unstructured":"Nakagawa T, Kishino S, Itoh S, Sugawara M, Miyazaki K. Differential binding of disopyramide and warfarin enantiomers to human \u03b11-acid glycoprotein variants. Br J Clin Pharmacol. 2003;56:664\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"9677_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jps.2600810104","volume":"81","author":"T Maruyama","year":"1992","unstructured":"Maruyama T, Furuie MA, Hibino S, Otagiri M. Comparative study of interaction mode of diazepines with human serum albumin and \u03b11-acid glycoprotein. J Pharm Sci. 1992;81:16\u201320.","journal-title":"J Pharm Sci"},{"key":"9677_CR25","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/jm991174y","volume":"43","author":"A Frostell-Karlsson","year":"2000","unstructured":"Frostell-Karlsson A, Remaeus A, Roos H, Andersson K, Borg P, Hamalainen M, et al. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J Med Chem. 2000;43:1986\u201392.","journal-title":"J Med Chem"},{"key":"9677_CR26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1021\/ac970766q","volume":"70","author":"A Amini","year":"1998","unstructured":"Amini A, Westerlund D. Evaluation of association constants between drug enantiomers and human \u03b11-acid glycoprotein by applying a partial-filling technique in affinity capillary electrophoresis. Anal Chem. 1998;70:1425\u201330.","journal-title":"Anal Chem"},{"key":"9677_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ab.2008.01.035","volume":"376","author":"R Mallik","year":"2008","unstructured":"Mallik R, Xuan H, Guiochon G, Hage DS. Immobilization of \u03b11-acid glycoprotein for chromatographic studies of drug-protein binding II. correction for errors in association constant measurements. Anal Biochem. 2008;376:154\u20136.","journal-title":"Anal Biochem"},{"key":"9677_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.chroma.2007.03.063","volume":"1149","author":"R Mallik","year":"2007","unstructured":"Mallik R, Xuan H, Hage DS. Development of an affinity silica monolith containing \u03b11-acid glycoprotein for chiral separations. J Chromatogr A. 2007;1149:294\u2013304.","journal-title":"J Chromatogr A"},{"key":"9677_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ab.2005.08.025","volume":"346","author":"H Xuan","year":"2005","unstructured":"Xuan H, Hage DS. Immobilization of \u03b11-acid glycoprotein for chromatographic studies of drug-protein binding. Anal Biochem. 2005;346:300\u201310.","journal-title":"Anal Biochem"},{"key":"9677_CR30","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/jssc.201000214","volume":"33","author":"H Xuan","year":"2010","unstructured":"Xuan H, Joseph KS, Wa C, Hage DS. Biointeraction analysis of carbamazepine binding to \u03b11-acid glycoprotein by high-performance affinity chromatography. J Sep Sci. 2010;33:2294\u2013301.","journal-title":"J Sep Sci"},{"key":"9677_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jchromb.2006.02.053","volume":"834","author":"SS Singh","year":"2006","unstructured":"Singh SS, Mehta J. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration. J Chromatogr B. 2006;834:108\u201316.","journal-title":"J Chromatogr B"},{"key":"9677_CR32","volume-title":"Immobilized affinity ligand techniques","author":"GT Hermanson","year":"1992","unstructured":"Hermanson GT, Mallia AK, Smith PK. Immobilized affinity ligand techniques. San Diego: Academic; 1992."},{"key":"9677_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10971-006-8132-1","volume":"40","author":"TR Besanger","year":"2006","unstructured":"Besanger TR, Brennan JD. Entrapment of membrane proteins in sol\u2013gel derived silica. J Sol\u2013gel Sci Techn. 2006;40:209\u201325.","journal-title":"J Sol\u2013gel Sci Techn"},{"key":"9677_CR34","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1021\/cm010119m","volume":"13","author":"T Keeling-Tucker","year":"2001","unstructured":"Keeling-Tucker T, Brennan JD. Fluorescent probes as reporters on the local structure and dynamics in sol\u2013gel-derived nanocomposite materials. Chem Mater. 2001;13:3331\u201350.","journal-title":"Chem Mater"},{"key":"9677_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ab.2007.08.036","volume":"373","author":"LE Vera-Avila","year":"2008","unstructured":"Vera-Avila LE, Garcia-Salgado E, de Llasera Garcia MP, Pena-Alvarez A. Binding characteristics of bovine serum albumin encapsulated in sol\u2013gel glasses: an alternative for protein interaction studies. Anal Biochem. 2008;373:272\u201380.","journal-title":"Anal Biochem"},{"key":"9677_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ab.2010.05.004","volume":"404","author":"AJ Jackson","year":"2010","unstructured":"Jackson AJ, Xuan H, Hage DS. Entrapment of proteins in glycogen-capped and hydrazide-activated supports. Anal Biochem. 2010;404:106\u20138.","journal-title":"Anal Biochem"},{"key":"9677_CR37","first-page":"35","volume-title":"Handbook of affinity chromatography","author":"HS Kim","year":"2006","unstructured":"Kim HS, Hage DS. Immobilization methods for affinity chromatography. In: Hage DS, editor. Handbook of affinity chromatography. 2nd ed. Boca Raton: CRC Press; 2006. p. 35\u201378.","edition":"2"},{"key":"9677_CR38","unstructured":"Bi C, Jackson A, Vargas-Badilla J, Li R, Rada G, Anguizola J, Pfaunmiller E, Hage DS. Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies. J Chromatogr B. In press."},{"key":"9677_CR39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1021\/cm202798e","volume":"24","author":"MRN Monton","year":"2012","unstructured":"Monton MRN, Forsberg EM, Brennan JD. Tailoring sol\u2013gel-derived silica materials for optical biosensing. Chem Mater. 2012;24:796\u2013811.","journal-title":"Chem Mater"},{"key":"9677_CR40","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","volume":"405","author":"AJ Jackson","year":"2013","unstructured":"Jackson AJ, Anguizola J, Pfaunmiller E, Hage DS. Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin. Anal Bioanal Chem. 2013;405:5833\u201341.","journal-title":"Anal Bioanal Chem"},{"key":"9677_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jchromb.2014.01.026","volume":"968","author":"X Zheng","year":"2014","unstructured":"Zheng X, Li Z, Beeram S, Podariu M, Matsuda R, Pfaunmiller E, et al. Analysis of biomolecular interactions using affinity microcolumns: a review. J Chromatogr B. 2014;968:49\u201363.","journal-title":"J Chromatogr B"},{"key":"9677_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0021-9673(94)80332-3","volume":"669","author":"PF Ruhn","year":"1994","unstructured":"Ruhn PF, Garver S, Hage DS. Development of dihydrazide-activated silica supports for high-performance affinity chromatography. J Chromatogr A. 1994;669:9\u201319.","journal-title":"J Chromatogr A"},{"key":"9677_CR43","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/jssc.200900346","volume":"32","author":"MJ Yoo","year":"2009","unstructured":"Yoo MJ, Hage DS. Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions. J Sep Sci. 2009;32:2776\u201385.","journal-title":"J Sep Sci"},{"key":"9677_CR44","unstructured":"Vargas-Badilla J. Applications of high performance affinity chromatography with high capacity stationary phases made by entrapment. PhD Dissertation, University of Nebraska-LIncoln, Lincoln, NE. 2015."},{"key":"9677_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00216-012-5816-y","volume":"403","author":"MR Sobansky","year":"2012","unstructured":"Sobansky MR, Hage DS. Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography. Anal Bioanal Chem. 2012;403:563\u201371.","journal-title":"Anal Bioanal Chem"},{"key":"9677_CR46","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1021\/ac970565m","volume":"69","author":"SA Tweed","year":"1997","unstructured":"Tweed SA, Loun B, Hage DS. Effects of ligand heterogeneity in the characterization of affinity columns by frontal analysis. Anal Chem. 1997;69:4790\u20138.","journal-title":"Anal Chem"},{"key":"9677_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chroma.2015.12.084","volume":"1432","author":"C Bi","year":"2016","unstructured":"Bi C, Zheng X, Hage DS. Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using \u03b11-acid glycoprotein microcolumns. J Chromatogr A. 2016;1432:49\u201357.","journal-title":"J Chromatogr A"},{"key":"9677_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbagen.2007.01.009","volume":"1770","author":"F Zsila","year":"2007","unstructured":"Zsila F, Iwao Y. The drug binding site of human \u03b11-acid glycoprotein: insight from induced circular dichroism and electronic absorption spectra. Biochim Biophys Acta. 2007;1770:797\u2013809.","journal-title":"Biochim Biophys Acta"},{"key":"9677_CR49","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/jssc.200600051","volume":"29","author":"H Xuan","year":"2006","unstructured":"Xuan H, Hage DS. Evaluation of a hydrazide-linked \u03b11-acid glycoprotein chiral stationary phase: separation of R- and S-propranolol. J Sep Sci. 2006;29:1412\u201322.","journal-title":"J Sep Sci"},{"key":"9677_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00008571-199610000-00004","volume":"6","author":"F Herve","year":"1996","unstructured":"Herve F, Duche JC, d\u2019Athis P, Marche C, Barre J, Tillement JP. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human \u03b11-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on \u03b11-acid glycoprotein. Pharmacogenetics. 1996;6:403\u201315.","journal-title":"Pharmacogenetics"},{"key":"9677_CR51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/mol.54.1.129","volume":"54","author":"F Herve","year":"1998","unstructured":"Herve F, Caron G, Duche JC, Gaillard P, Rahman NA, Tsantili-Kakoulidou A, et al. Ligand specificity of the genetic variants of human \u03b11-acid glycoprotein: generation of a three-dimensional quantitative structure-activity relationship model for drug binding to the A variant. Mol Pharmacol. 1998;54:129\u201338.","journal-title":"Mol Pharmacol"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-016-9677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-016-9677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-016-9677-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-016-9677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:51:53Z","timestamp":1589622713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-016-9677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,11]]},"references-count":51,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9677"],"URL":"https:\/\/doi.org\/10.1007\/s00216-016-9677-7","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,11]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest in the work that is presented in this study. The general concept of the entrapment approach that was used in this work is described in U.S. Patent 8,268,570.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}